Bcl-X(L) is heterogeneously expressed by acute myeloblastic leukaemia cells and is associated with autonomous growth in vitro and with P-glycoprotein expression

Leukemia

Volumn 11, Issue 7, 1997, Pages 945-949

  Pallis, M ^a   Zhu, Y M ^a   Russell, N H ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

AML; Autonomous growth; Bcl X(L); P glycoprotein

Indexed keywords

CYTOTOXIC AGENT; GLYCOPROTEIN P; PROTEIN BCL 2;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; ONCOGENE; PRIORITY JOURNAL;

EID: 0030837332     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400705     Document Type: Article

References (22)

1. Reilly IAG, Kozlowski R, Russell NH. Heterogenous mechanisms of autocrine growth of AML blasts. Br J Haematol 1989; 72: 363-369.
2. Bradbury D, Zhu Y-M, Russell N. Regulation of bcl-2 expression and apoptosis in acute myeloblastic leukaemia cells by granulocyte-macrophage colony-stimulating factor. Leukaemia 1994; 8: 786-791.
3. Lowenberg B, van Putten WLJ, Touw IP, Dewel R, Santini V. Autonomous proliferation of leukaemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. New Engl J Med 1992; 328: 614-619.
4. Hunter AE, Rogers SY, Reilly IAG, Barrett AJ, Russell NH. Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia. Blood 1993; 82: 899-903.
5. Lotem J, Sachs L. Control of apoptosis in haematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes. Leukemia 1996; 10: 925-931.
6. Boise LH, Gonzalez-Garcia M, Postema CE et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apopototic cell death. Cell 1993; 74: 597-608.
7. Kamesaki S, Kamesaki H, Jorgensen TJ, Tanizawa A, Pommier Y, Cossman J. bcl-2 protein inhibits etoposide-induced apoptosis through its effect on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res 1993; 53:4251-4256.
8. Walton MI, Whysong D, O'Connor PM, Hockenbery D, Korsmeyer SJ, Kohn KW. Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin induced apopotosis. Cancer Res 1993; 53: 1853-1861.
9. L can confer a multidrug resistance phenotype. Blood 1995; 86: 1903-1910.
10. Sonneveld P. Multidrug resistance in acute myeloid leukaemia. Balliere's Clin Haematol 1996; 9: 185-203.
11. Campos L, Guyotat D, Archimbaud E et al. Clinical significance of multidrug resistance P-glycoprotein expression on acute non-lymphoblastic leukaemia cells at diagnosis. Blood 1992; 79: 473-476.
12. Leith CP, Chen IM, Kopecky KJ et al. Correlation of multidrug resistance (MDR-1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux-cases. Blood 1995; 86: 2329-2342.
13. Guerci A, Merlin JL, Missoum N et al. Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry. Blood 1995; 85: 2147-2153.
14. Del Poeta G, Stasi R, Aronica G et al. Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood 1996; 87: 1997-2004.
15. L by cytotoxic drug exposure confers resistance to ionising radiation-induced internucleosomal DNA fragmentation. Cell Growth Diff 1995; 6: 363-370.
16. Flens MJ, Izquierdo MA, Scheffer GL et al. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug resistant tumour cells by monoclonal antibodies. Cancer Res 1994; 54: 4557-4563.
17. Pallis M, Robins RA, Powell RJ. Peripheral blood lymphocyte adhesion molecule deployment in the immune response. Scand J Immunol 1996; 43: 304-313.
18. Vogt RF, Henderson LO, Ethridge SF, Huang EY, White JT, Meredith NK. Lymphocyte immunophenotyping with extended quantitative analysis of listmode files for epidemiological health studies. Ann NY Acad Sci 1993; 677: 462-464.
19. + acute myeloid leukemia cells. Blood 1993; 10: 3157-3162.
20. Park JR, Bernstein ID, Hockenbery DM. Primitive human hematopoietic precursors express bcl-x but not bcl-2. Blood 1995; 86: 868-876.
21. L and bax in the control of apoptosis by hemopoietic cytokines and dexamethasone. Cell Growth Diff 1995; 6: 647-653.
22. Campos L, Rouault J-P, Sabiolo O et al. High expression of bcl-2 protein in acute myeloid leukaemia cells is associated with poor response to chemotherapy. Blood 1993; 81: 3091-3096.